Suchergebnisse - "Zhang, Guochao"

PubPharm (8)

1

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

enthalten in: Journal of translational medicine | 2022

von Sun, N. | Luo, Y. | Zheng, B. | +8

2

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

enthalten in: Journal of translational medicine | 2022

von Sun, N. | Luo, Y. | Zheng, B. | +8

3

A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma

enthalten in: Journal of translational medicine | 2022

von Sun, N. | Luo, Y. | Zheng, B. | +8

4

The combination of novel immune checkpoints HHLA2 and ICOSLG : A new system to predict survival and immune features in esophageal squamous cell carcinoma

enthalten in: Genes & diseases | 2022

von Zhang, C. | Wang, F. | Sun, N. | +8

5

m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

enthalten in: BMC medicine | 2021

von Zhang, Z. | Zhang, C. | Luo, Y. | +13

6

$ m^{6} $A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer

enthalten in: BMC medicine | 2021

von Zhang, Z. | Zhang, C. | Luo, Y. | +13

7

The immunotherapy with hMASP-2 DNA nanolipoplexes against echinococcosis in experimentally protoscolex-infected mice

enthalten in: Acta tropica | 2020

von Chen, C. | Gao, Q. | Luo, Y. | +7

8

Comprehensive molecular analyses of a TNF family-based signature with regard to prognosis, immune features, and biomarkers for immunotherapy in lung adenocarcinoma

enthalten in: EBioMedicine | 2020

von Zhang, C. | Zhang, G. | Sun, N. | +6

1
[1]